Oric Pharmaceuticals, Inc. ORIC Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$129.47M-1.3% | -$127.85M-27.0% | -$100.7M-13.0% | -$89.12M-13.2% | ||
| $1.22M+10.2% | $1.11M+7.3% | $1.03M+6.8% | $966K+7.7% | ||
| $25.04M+23.9% | $20.21M+32.8% | $15.23M+5.3% | $14.46M+12.5% | ||
| —— | —— | $3.28M— | —— | ||
| -$1.79M-1,150% | -$143K— | —— | -$1.03M— | ||
| -$110.97M+1.5% | -$112.66M-31.5% | -$85.69M-14.0% | -$75.14M-26.2% | ||
| $712K-40.1% | $1.19M+39.9% | $849K-59.1% | $2.08M+121% | ||
| $399.82M+58.7% | $251.92M+5.3% | $239.24M+0.5% | $238.12M+242% | ||
| —— | —— | —— | —— | ||
| $244.37M— | —— | —— | $25M-50.0% | ||
| $245.26M+93.8% | $126.55M+47.7% | $85.66M+240% | $25.23M-48.7% | ||
| -$13.74M— | —— | -$43.43M— | —— | ||
| $2.3M-71.6% | $8.1M+31.4% | $6.17M+492% | $1.04M+177% | ||
| $1.22M+10.2% | $1.11M+7.3% | $1.03M+6.8% | $966K+7.7% | ||
| -$1.79M-1,150% | -$143K— | —— | -$1.03M— | ||
| —— | —— | —— | —— | ||
| $2.4M— | —— | —— | —— | ||
| -$111.68M+1.9% | -$113.85M-31.6% | -$86.54M-12.1% | -$77.22M-27.7% | ||
| -$111.68M+1.9% | -$113.85M-31.6% | -$86.54M-12.1% | -$77.22M-27.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Oric Pharmaceuticals, Inc. generate?
- Oric Pharmaceuticals, Inc. (ORIC) generated -$110.9M in operating cash flow over the trailing twelve months.
- What is Oric Pharmaceuticals, Inc.'s free cash flow?
- After $327.0K of capital expenditures, Oric Pharmaceuticals, Inc.'s free cash flow was -$111.2M over the trailing twelve months, up 4.4% year over year.
- Where does Oric Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Oric Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.